ArticleScientific reports2025
In tendons, differing physiological requirements lead to distinct patterns of MMP-1 degradation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Collagen fibrils from high-stress, energy-storing tendons critical to locomotion are smaller in diameter with increased intermolecular crosslinking compared to fibrils from low-stress, positional tendons. This results in distinct loading mechanics thought to limit fatigue damage in energy-storing tendons. However, there appears to be a functional trade-off with energy-storing tendons also having reduced remodeling ability. Energy-storing tendons have lower collagen turnover and increased injury rates compared to positional tendons. In a recent study, a causative factor for this lower collagen turnover was suggested: resistance to degradation by MMP-1. To validate the prior study's results obtained from single fibrils, the current study undertook population level assessment of fibril degradation by MMP-1. Predictive degradation models were created to assess fibril diameter distribution changes. Positional and energy-storing tendon sections were incubated for 24 h with buffer or MMP-1, imaged with scanning electron microscopy, and analysed with a custom pipeline for piece-wise fibril measurement. Enzyme treated sections showed evidence of degradation with reduced fibril diameter, decreased alignment, increased curvature, and decreased D-band length. Energy-storing tendon fibrils were more resistant to enzymolysis, with only the large diameter fibril subpopulation affected by MMP-1 (15% diameter reduction compared to control), while the entire population of positional tendon fibrils decreased in diameter (41%). Comparison to model predictions confirmed a linear relationship of degradation with fibril size. Larger fibrils experienced greater diameter decreases combined with increased longitudinal diameter variation and D-band decreases. Crosslinking is thought to be responsible for both fibril type and size findings, the latter suggesting higher density crosslinking in the fibril core.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.